Barclays’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$699K Buy
140,254
+164
+0.1% +$817 ﹤0.01% 2864
2025
Q1
$618K Sell
140,090
-25,838
-16% -$114K ﹤0.01% 2716
2024
Q4
$772K Buy
165,928
+25,815
+18% +$120K ﹤0.01% 2789
2024
Q3
$973K Buy
140,113
+130,219
+1,316% +$904K ﹤0.01% 2638
2024
Q2
$78K Sell
9,894
-19,500
-66% -$154K ﹤0.01% 3492
2024
Q1
$208K Buy
29,394
+9,483
+48% +$67.1K ﹤0.01% 3318
2023
Q4
$134K Buy
19,911
+1,051
+6% +$7.07K ﹤0.01% 3636
2023
Q3
$106K Buy
18,860
+351
+2% +$1.97K ﹤0.01% 3312
2023
Q2
$102K Buy
18,509
+12,722
+220% +$70.1K ﹤0.01% 3389
2023
Q1
$36K Hold
5,787
﹤0.01% 3859
2022
Q4
$26K Buy
5,787
+216
+4% +$970 ﹤0.01% 3974
2022
Q3
$26K Sell
5,571
-36,612
-87% -$171K ﹤0.01% 3852
2022
Q2
$250K Buy
42,183
+17,322
+70% +$103K ﹤0.01% 3022
2022
Q1
$480K Buy
+24,861
New +$480K ﹤0.01% 2838